PARTENAR-IA — CQDM — Industry

📋 Eligible Entities - Small and medium-sized enterprises (SMEs) operating in Canada - Start-ups with innovative AI capabilities - Must be for-profit organizations - Must partner with an eligible research centre (university, government lab, or recognized research institution) - Must demonstrate capacity to commercialize AI solutions in drug discovery - Quebec-based entities are prioritized (CQDM = Consortium for Drug Discovery in Quebec) ### 💰 Funding Details - Grant amount: Up to $1.5 million per project - Coverage rate: Maximum 35% of eligible project expenses - Repayability: Non-refundable grant (no repayment required) - Matching requirement: Applicant must cover minimum 65% of eligible costs through own resources or third-party contributions - Currency: Canadian dollars - Funding model: Cost-sharing arrangement with public sector support ### 🛠️ Approved Expenses - Research & development activities in artificial intelligence for drug discovery - Personnel costs for dedicated project team members (scientists, engineers, researchers) - Technology and software development and licensing - Equipment and infrastructure directly supporting AI research - Consulting and professional services related to project execution - Data acquisition and management systems for drug discovery pipelines - Prototyping and validation of AI-driven drug discovery solutions - Regulatory and intellectual property support to advance commercialization ### ⚠️ Conditions & Milestones - Partnership requirement: Formal collaboration agreement with accredited research centre must be in place before application - AI focus: Project must demonstrate clear application of artificial intelligence to drug discovery acceleration - Commercialization intent: Business plan must show credible path to market and commercialization - Reporting obligations: Recipient must provide regular progress reports and financial statements - Intellectual property: Terms governing ownership and licensing of resulting IP must be defined upfront - Project duration: Typically 2-3 years (exact timeline specified in funding agreement) - Use of funds: Expenses must be incurred during approved project period; no retroactive funding - Audit rights: Government